Bausch Health CEO gets 815,425-share RSU award

Bausch Health Companies Inc. director and Chief Executive Officer Thomas Appio reported two equity compensation transactions involving the company’s common shares.

Rhea-AI Filing Summary

Bausch Health Companies Inc. director and Chief Executive Officer Thomas Appio reported two equity compensation transactions involving the company’s common shares.

On February 25, 2026, he acquired 815,425 common shares at $0.00 per share as a grant of restricted share units (RSUs). According to the filing, these RSUs vest in three equal annual installments over three years and are settled in common shares upon vesting.

On February 26, 2026, 116,502 common shares were disposed of in a tax-withholding transaction at $6.04 per share to cover obligations arising from RSU vesting, rather than an open-market sale. Following these transactions, Appio directly owned 3,620,034 common shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider APPIO THOMAS

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Shares, No Par Value	116,502	$6.04	$704K
Grant/Award	Common Shares, No Par Value	815,425	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 3,620,034 shares (Direct)

Footnotes (2)

1. F1. Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
2. F2. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bausch Health (BHC) CEO Thomas Appio report in this Form 4?

Thomas Appio reported an equity grant and a tax-related share disposition. He received 815,425 restricted share units and had 116,502 common shares withheld to satisfy tax obligations tied to vesting RSUs.

How many Bausch Health (BHC) shares were granted to CEO Thomas Appio?

Thomas Appio was granted 815,425 restricted share units tied to Bausch Health common shares. These RSUs vest in three equal annual installments and are settled in common shares as they vest, reflecting a multi-year equity compensation award.

Was the 116,502-share transaction by Bausch Health (BHC) CEO an open-market sale?

No, the 116,502-share transaction was not an open-market sale. The shares were withheld to cover tax withholding obligations arising from the vesting of restricted share units previously granted to Thomas Appio.

How do the new RSUs for Bausch Health (BHC) CEO vest over time?

The new restricted share units granted to Thomas Appio vest over three years. One-third of the 815,425 units will vest on each of the first three anniversaries of the grant date, assuming he continues in service.

What is Thomas Appio’s direct Bausch Health (BHC) share ownership after these transactions?

After the reported grant and tax-withholding disposition, Thomas Appio directly owned 3,620,034 Bausch Health common shares. This figure reflects his holdings following settlement and withholding related to his equity compensation.

What do the RSU awards mean for Bausch Health (BHC) CEO compensation?

The RSU awards represent stock-based compensation for Thomas Appio. The 815,425 restricted share units align his compensation with long-term company performance, as they vest over three years and convert into common shares when vesting occurs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 05:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

APPIO THOMAS

(Last) (First) (Middle)

400 SOMERSET CORPORATE BOULEVARD

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/25/2026		A		815,425(1)	A	$0	3,736,536	D
Common Shares, No Par Value	02/26/2026		F		116,502(2)	D	$6.04	3,620,034	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

2. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

	/s/ Brianna M. Dorsi attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.